ArticleJournal of central nervous system disease2022

How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?

Stefan Braune et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.